Free Trial

Candel Therapeutics (CADL) SEC Filings & 10K Form

Candel Therapeutics logo
$6.88 -0.62 (-8.27%)
As of 01:46 PM Eastern

Recent Candel Therapeutics SEC Filings

DateFilerForm TypeView
03/20/2025
3:35 PM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4/A
03/20/2025
3:35 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:36 PM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:36 PM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:12 PM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:28 PM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:29 PM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:29 PM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:29 PM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:29 PM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:45 PM
Candel Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
12:35 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:15 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:32 PM
Candel Therapeutics (Subject)
Northpond Ventures, LP (Filed by)
Form SCHEDULE 13G/A
02/14/2025
3:30 PM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
5:25 AM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:09 PM
Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:18 AM
Candel Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:03 AM
Candel Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G
01/15/2025
7:30 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:05 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:30 PM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM
Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:27 AM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:27 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:28 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:28 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:29 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/30/2024
6:37 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
12:59 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Final Plan (Ad)

Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.

12/18/2024
3:11 PM
Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
11:30 AM
Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
12/13/2024
5:12 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:30 PM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
3:36 PM
Candel Therapeutics (Filer)
Form 424B5
12/12/2024
3:55 PM
Candel Therapeutics (Filer)
Form 424B5
12/11/2024
6:45 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
5:44 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:46 PM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:47 PM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:48 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:48 PM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
8:12 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
8:13 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
8:15 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
8:17 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
5:24 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
2:07 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
7:30 AM
Candel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
7:15 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:58 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
5:08 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
5:41 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
7:30 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:59 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:19 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
4:16 PM
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
4:53 PM
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
7:15 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:30 AM
Candel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
7:26 AM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:28 AM
Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:29 AM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:31 AM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:24 AM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
6:28 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:29 AM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:31 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:32 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:27 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
7:32 AM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:34 AM
Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:35 AM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:36 AM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:30 AM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
6:33 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
6:35 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
6:36 AM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
6:37 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
6:38 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s Final Plan (Ad)

Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.

06/28/2024
7:39 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:40 AM
Candel Therapeutics (Issuer)
Nguyen Diem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:41 AM
Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:34 AM
Benz Edward J. JR (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:35 AM
Candel Therapeutics (Issuer)
Gaeta Renee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:36 AM
Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:37 AM
Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:39 AM
Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:39 AM
Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CADL) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners